Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 • 5,657 citations
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
1996 • 2,408 citations
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
2001 • 1,520 citations
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
1999 • 1,447 citations
How Proteolysis Drives the Cell Cycle
1996 • 1,277 citations
NF-κB as a Therapeutic Target in Multiple Myeloma
2002 • 906 citations
Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
2001 • 544 citations
The Proteasome, a Novel Protease Regulated by Multiple Mechanisms
1999 • 540 citations
Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
2001 • 481 citations
The ubiquitin‐proteasome pathway and proteasome inhibitors
2001 • 428 citations
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
2001 • 420 citations
Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm.
1994 • 395 citations
The role of the ubiquitin-proteasome pathway in apoptosis
1999 • 382 citations
Biologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications
2002 • 382 citations
The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression
1995 • 354 citations
Proteasome Inhibition Measurements: Clinical Application
2000 • 308 citations
Catalytic Activities of the 20 S Proteasome, a Multicatalytic Proteinase Complex
2000 • 301 citations
Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
1998 • 277 citations
Dynamics of proteasome distribution in living cells
1997 • 269 citations
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer
2001 • 263 citations
Proteasome inhibitors as potential novel anticancer agents
1999 • 157 citations
Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia.
2002 • 145 citations
The Proteasome Is Involved in Angiogenesis
1998 • 131 citations
Regulation of transcription factors by protein degradation
2000 • 99 citations
S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.
2002 • 90 citations
The specificity of proteasomes: impact on MHC class I processing and presentation of antigens
1999 • 76 citations
Proteasome inhibitors: fromin vitro uses to clinical trials
2000 • 39 citations
Cited By (0)
No citing papers found in database